Bumper Offer - Urjas oil Just @ Rs. 1
Tri Olvance 40 Tablet is a commercial drug that is prescribed in the form of Tablet. Other than this, Tri Olvance 40 Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Tri Olvance 40 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Common side effects of Tri Olvance 40 Tablet include Upper respiratory tract infection. Besides the aforementioned side effects, there are other adverse effects of Tri Olvance 40 Tablet as well, which are listed below. Such side effects of Tri Olvance 40 Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Tri Olvance 40 Tablet is Safe for pregnant women and Safe for women who are breastfeeding. It is important to know if Tri Olvance 40 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Tri Olvance 40 Tablet related warnings section.
Individuals suffering from medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) must refrain from the use of Tri Olvance 40 Tablet since this can cause severe adverse effects. Other contraindications of Tri Olvance 40 Tablet have been discussed in the sections ahead.
Besides this, Tri Olvance 40 Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to the above precautions for Tri Olvance 40 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Tri Olvance 40 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Tri Olvance 40 Tablet is used -
Moderate
Mild
Is the use of Tri Olvance 40 Tablet safe for pregnant women?
Tri Olvance is safe for pregnant women.
Is the use of Tri Olvance 40 Tablet safe during breastfeeding?
Tri Olvance is safe for breastfeeding women.
What is the effect of Tri Olvance 40 Tablet on the Kidneys?
Tri Olvance has very mild side effects on the kidneys.
What is the effect of Tri Olvance 40 Tablet on the Liver?
Very few cases of side effects of Tri Olvance on the liver have been reported.
What is the effect of Tri Olvance 40 Tablet on the Heart?
Very few cases of side effects of Tri Olvance on the heart have been reported.
Tri Olvance 40 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tri Olvance 40 Tablet unless your doctor advises you to do so -
Is this Tri Olvance 40 Tablet habit forming or addictive?
Tri Olvance 40 Tablet is not addictive in nature.
Interaction between Food and Tri Olvance 40 Tablet
When consumed with certain foods, Tri Olvance 40 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Tri Olvance 40 Tablet
Consuming Tri Olvance 40 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
